BR112017005133A2 - methods for enhancing, improving or maintaining cognitive health and / or function, for treating or preventing a decline in cognitive health and / or function, and for improving mood and sleep in a mammal - Google Patents

methods for enhancing, improving or maintaining cognitive health and / or function, for treating or preventing a decline in cognitive health and / or function, and for improving mood and sleep in a mammal

Info

Publication number
BR112017005133A2
BR112017005133A2 BR112017005133-8A BR112017005133A BR112017005133A2 BR 112017005133 A2 BR112017005133 A2 BR 112017005133A2 BR 112017005133 A BR112017005133 A BR 112017005133A BR 112017005133 A2 BR112017005133 A2 BR 112017005133A2
Authority
BR
Brazil
Prior art keywords
extract
plant
day
sleep
administered
Prior art date
Application number
BR112017005133-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Ceddia Michael
Herrlinger Kelli
Lewis Brandon
Nieman Kristin
Feng Shulin
Original Assignee
Kemin Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries, Inc. filed Critical Kemin Industries, Inc.
Publication of BR112017005133A2 publication Critical patent/BR112017005133A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112017005133-8A 2014-09-15 2015-09-15 methods for enhancing, improving or maintaining cognitive health and / or function, for treating or preventing a decline in cognitive health and / or function, and for improving mood and sleep in a mammal BR112017005133A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050563P 2014-09-15 2014-09-15
US62/050563 2014-09-15
PCT/US2015/050230 WO2016044299A1 (en) 2014-09-15 2015-09-15 Plant extracts for improving cognitive function

Publications (1)

Publication Number Publication Date
BR112017005133A2 true BR112017005133A2 (en) 2018-01-23

Family

ID=55453722

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005133-8A BR112017005133A2 (en) 2014-09-15 2015-09-15 methods for enhancing, improving or maintaining cognitive health and / or function, for treating or preventing a decline in cognitive health and / or function, and for improving mood and sleep in a mammal

Country Status (8)

Country Link
US (2) US10857195B2 (https=)
EP (1) EP3194028A4 (https=)
JP (3) JP2017527591A (https=)
KR (2) KR20240000637A (https=)
AU (1) AU2015317990B2 (https=)
BR (1) BR112017005133A2 (https=)
CA (1) CA2961378A1 (https=)
WO (1) WO2016044299A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
CN116474049A (zh) * 2023-03-17 2023-07-25 深圳福图仁泰生物科技有限公司 一种兼具抗抑郁和促睡眠功效的植物天然水溶性复合物及其制备方法和应用
GB202402670D0 (en) * 2024-02-26 2024-04-10 Givaudan Sa Composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752476A (en) * 1986-02-18 1988-06-21 Copney Claudette V Sleep aiding herbal composition and method of utilizing same
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
JP2002275061A (ja) * 2001-03-19 2002-09-25 Tsumura & Co 抗うつ・抗不安剤
JP3947149B2 (ja) * 2002-10-28 2007-07-18 高砂香料工業株式会社 消臭剤組成物
CN1566300A (zh) * 2003-07-09 2005-01-19 新疆芳香植物科技开发股份有限公司 制造香囊、香枕的芳香组合物及其制备方法
JP2005053891A (ja) * 2003-07-18 2005-03-03 Seresu Corporation:Kk リパーゼ阻害剤
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
US20100137433A1 (en) * 2007-01-24 2010-06-03 Laima Kott Production of Rosmarinic Acid from Spearmint and uses Thereof
WO2008122099A1 (en) * 2007-04-05 2008-10-16 Iomedix Development International Srl Composition for promoting sleep and relaxation comprising lemon balm
ES2561330T3 (es) * 2007-10-17 2016-02-25 Rudolf Wild Gmbh & Co. Kg Composición que comprende extractos de toronjil
WO2009106121A1 (en) * 2008-02-25 2009-09-03 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway
JP2010106001A (ja) 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤
EP2398340A2 (en) * 2009-02-20 2011-12-28 DSM IP Assets B.V. Oregano extract for alertness
CN102958529B (zh) * 2009-12-21 2015-12-09 马来西亚热带生物有限公司 有益地用作认知增强剂的肾茶提取物
US9545076B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0042
US9545075B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0110
JP5668258B2 (ja) * 2011-10-21 2015-02-12 ザ マッキス カンパニー インコーポレイテッド エゴマの葉マッコリ及びその製造方法
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
US20140302170A1 (en) * 2013-04-08 2014-10-09 Scientific Nutrition Products, Inc. Compositions and methods for promoting sleep
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物

Also Published As

Publication number Publication date
US20160074459A1 (en) 2016-03-17
EP3194028A1 (en) 2017-07-26
JP2017527591A (ja) 2017-09-21
AU2015317990A1 (en) 2017-04-06
KR20170054501A (ko) 2017-05-17
KR20240000637A (ko) 2024-01-02
JP7818640B2 (ja) 2026-02-20
WO2016044299A1 (en) 2016-03-24
JP2024075715A (ja) 2024-06-04
EP3194028A4 (en) 2018-10-10
JP2022084873A (ja) 2022-06-07
AU2015317990B2 (en) 2020-04-30
CA2961378A1 (en) 2016-03-24
US20160166629A1 (en) 2016-06-16
US10857195B2 (en) 2020-12-08

Similar Documents

Publication Publication Date Title
JP7360267B2 (ja) 認知機能を向上させるための植物抽出物
JP7818640B2 (ja) 睡眠を改善するための植物抽出物
Farokhnia et al. N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
Sarris et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence
Khayat et al. Curcumin attenuates severity of premenstrual syndrome symptoms: A randomized, double-blind, placebo-controlled trial
Salerno-Kennedy et al. Relationship between dementia and nutrition-related factors and disorders: an overview
Seo et al. Effect of MIND diet on cognitive function in elderly: a narrative review with emphasis on bioactive food ingredients
Manzoor et al. A Comprehensive Review on Anxiolytic Effect of Lavandula Angustifolia Mill. in Clinical Studies
Mannaa et al. Efficacy of fish liver oil and propolis as neuroprotective agents in pilocarpine epileptic rats treated with valproate
US11357810B2 (en) Compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil having synergistic effects for improving memory, focus, and cognitive function, and related methods
Recart et al. Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase
Bongartz et al. Sleep Promoting Effects of IQP‐AO‐101: A Double‐Blind, Randomized, Placebo‐Controlled Exploratory Trial
Tarfarosh et al. Search for a perfect Nootropic supplement combination-Can we increase human intelligence by nutritional supplements
US20250387447A1 (en) Herbal composition for use in the improvement of physical and mental health recovery and maintenance, including the improvement of cognitive function or prevention of cognitive decline
Kelly et al. Integrative Approaches to Cognitive Decline
RS20230880A1 (sr) Preparat i njegova primena kod atopijskog dermatitisa kod dece
Nair Role of Dietary Supplements on Mental Function
Myers Ingredients for active aging
Owaga et al. Nutritional management of mental disorders: Potential role of dietary flavonoids and vitamin E
Marina et al. FOR A BETTER QUALITY OF LIFE IN ELDERLY.
Chen et al. Nutritional Approaches in Alzheimer's Disease Prevention
Johnson Natural Stress Relief
Vitetta The effects of an extract of Pinus radiata pine bark (Enzogenol®) on cognitive function in individuals at risk of cognitive decline

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]